Tabla 1: Descripción general de la población y comparación entre los dos grupos de estudio. |
||||
|
Total N = 58 |
Continua N = 29 |
Intermitente N = 29 |
p |
Sexo, n (%) |
||||
Masculino |
31 (53.4) |
13 (44.8) |
18 (62) |
0.192 |
Femenino |
27 (46.6) |
16 (55.2) |
11 (38) |
0.192 |
Edad [años]* |
50 (36-65) |
49 (38-62) |
51 (36-67) |
0.646 |
Peso [kg]** |
73 ± 15 |
73 ± 15 |
73 ± 15 |
0.911 |
Talla [m]** |
1.63 ± 0.09 |
1.63 ± 0.09 |
1.63 ± 0.08 |
0.927 |
IMC [kg/m2]** |
27.6 ± 5.3 |
27 ± 5.1 |
27.7 ± 5.6 |
0.880 |
Estado nutricional, n (%) |
0.777 |
|||
Desnutrición |
14 (24.1) |
7 (24.1) |
7 (24.1) |
|
Normal |
26 (44.8) |
12 (41.4) |
14 (48.3) |
|
Sobrepeso |
14 (24.1) |
8 (27.6) |
6 (20.7) |
|
Obesidad grado I |
3 (5.2) |
2 (6.9) |
1 (3.4) |
|
Obesidad grado II |
0 |
0 |
0 |
|
Obesidad grado III |
1 (1.7) |
0 |
1 (3.4) |
|
Ingreso, n (%) |
||||
Médico |
29 (50.0) |
15 (51.7) |
14 (48.3) |
0.793 |
Quirúrgico |
29 (50.0) |
14 (48.3) |
15 (51.7) |
0.793 |
Escala [puntos] |
||||
NUTRIC* |
3 (1-4.75) |
1 (0-3) |
3 (2-5) |
0.016 |
APACHE II* |
15 (9.3-22) |
14 (7-19) |
16 (12-26) |
0.173 |
SOFA* |
9 (6-12.7) |
8 (5-10) |
11 (7-13) |
0.055 |
Norepinefrina [μg/kg/min]* |
0.17 (0.08-0.2) |
0.13 (0.05-0.2) |
0.2 (0.12-0.25) |
0.190 |
Dos vasopresores, n (%) |
6 (10.34) |
4 (13.8) |
2 (6.9) |
0.392 |
Linfocitos [× 103/μL]* |
1.14 (0.7-1.5) |
1.2 (0.8-1.6) |
1.1 (1.1-0.6) |
0.176 |
Albúmina [g/dL]** |
2.69 ± 0.62 |
2.7 ± 0.4 |
2.7 ± 0.8 |
0.802 |
Días de estancia en la UCI** |
4.8 ± 2.74 |
4.9 ± 2.8 |
4.7 ± 2.7 |
0.925 |
Desenlace, n (%) |
0.717 |
|||
Defunción |
9 (15.5) |
5 (17.2) |
4 (13.8) |
|
Egreso de la UCI |
49 (84.5) |
24 (82.8) |
25 (86.2) |
|
IMC = índice de masa corporal. NUTRIC = Nutrition Risk in the Critically Ill Score. APACHE II = Acute Physiology and Chronic Health Evaluation II. SOFA = Sequential Organ Failure Assessment. UCI = Unidad de Cuidados Intensivos. Valores expresados como: * mediana (1q-3q); ** media ± desviación estándar. |